A recent study reveals that unborn babies are exposed to a significantly wider range of “forever chemicals” – per- and polyfluoroalkyl substances (PFAS) – than previously understood, raising concerns about potential health impacts. Researchers have identified 42 confirmed or potentially identified PFAS chemicals in cord blood samples, many of which are not routinely screened for using traditional testing methods. This discovery underscores the pervasive nature of these chemicals in the environment and their ability to reach even the most vulnerable populations.
PFAS, known for their persistence in the environment and the human body, have been linked to a variety of health problems, including immune deficiencies, increased cholesterol levels, and certain types of cancer. The findings, published recently, highlight a critical gap in our understanding of prenatal PFAS exposure and its long-term consequences for child development and health. The study utilized a non-targeted approach to identify these chemicals, allowing for a more comprehensive assessment than previous methods.
Wider Range of PFAS Detected in Cord Blood
The research, conducted by scientists at Mount Sinai, identified a diverse array of PFAS in cord blood. Traditional methods typically focus on a limited number of these compounds, potentially underestimating the total exposure experienced by developing fetuses. The study found 42 confirmed or putatively identified PFAS chemicals in cord blood using this non-targeted approach according to Mount Sinai. Scientists at SciTechDaily also reported the identification of 42 PFAS chemicals in cord blood samples as reported by SciTechDaily.
PFAS are used in a wide variety of consumer and industrial products, including non-stick cookware, firefighting foam, and food packaging. They enter the environment through manufacturing processes, wastewater discharge, and the disposal of PFAS-containing products. Because they don’t break down easily, PFAS can accumulate in the environment and in living organisms, leading to widespread exposure.
Fetal Exposure Begins In Utero
Exposure to these chemicals isn’t limited to postnatal life. Research indicates that pregnant individuals are also exposed to PFAS, serving as the initial point of contact before these substances can transfer to the developing fetus via the umbilical cord. A 2022 Environmental Working Group (EWG) science review found that dozens of studies published in the past five years reported the presence of PFAS in cord blood as detailed by the EWG. The EWG review of 40 studies consistently detected a wide range of PFAS in cord blood, with 16 studies linking PFAS exposure to changes in cord blood lipids and harm to fetal and childhood development.
Further research has explored the connection between PFAS exposure and later-life health outcomes. At least 14 studies identified by the EWG found associations between PFAS in cord blood, detection of PFAS in childhood, increased risk of health impacts in adulthood, or a combination of these factors. These studies were conducted across multiple countries, including the U.S., Brazil, China, and Japan.
PFAS and Epigenetic Age Acceleration
Recent studies are also investigating the potential for PFAS exposure to influence epigenetic age acceleration (EAA), a measure of the discrepancy between an individual’s chronological and biological age. A study published in PubMed found that maternal serum concentrations of perfluorodecanoate (PFDA) were negatively associated with EAA in cord blood according to research published in PubMed. This suggests a potential pathway through which PFAS exposure could impact developmental processes.
Another study, published in January 2026, indicated that PFAS levels in cord serum are closely associated with birth outcomes as reported by ScienceDirect. While the specific mechanisms are still being investigated, these findings reinforce the need for further research into the long-term health effects of prenatal PFAS exposure.
The implications of these findings are significant, highlighting the urgent need for greater awareness and preventative measures. Reducing exposure to PFAS requires a multi-faceted approach, including stricter regulations on PFAS use, development of safer alternatives, and improved monitoring of PFAS levels in the environment and human populations.
Further research is planned to investigate the specific health effects of the newly identified PFAS chemicals and to determine the optimal strategies for minimizing prenatal exposure. Scientists will continue to monitor PFAS levels in cord blood and assess the long-term health outcomes of exposed children. The ongoing investigation into these “forever chemicals” is crucial for protecting the health of future generations.
This information is for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on these findings? Share your comments below, and please share this article with your network to raise awareness about the potential risks of PFAS exposure.
